rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
1999-7-22
|
pubmed:abstractText |
Refractory acute cellular rejection may occur despite triple-drug immunosuppression (cyclosporine A, steroids, azathioprine/mycophenolate mofetil). The purpose of this study was to determine the efficacy of tacrolimus rescue therapy in patients maintained on cyclosporine-based immunosuppression (CBI).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1053-2498
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
448-55
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10363689-Acute Disease,
pubmed-meshheading:10363689-Adult,
pubmed-meshheading:10363689-Aged,
pubmed-meshheading:10363689-Biopsy,
pubmed-meshheading:10363689-Cyclosporine,
pubmed-meshheading:10363689-Drug Therapy, Combination,
pubmed-meshheading:10363689-Female,
pubmed-meshheading:10363689-Follow-Up Studies,
pubmed-meshheading:10363689-Glucocorticoids,
pubmed-meshheading:10363689-Graft Rejection,
pubmed-meshheading:10363689-Heart-Lung Transplantation,
pubmed-meshheading:10363689-Humans,
pubmed-meshheading:10363689-Immunosuppressive Agents,
pubmed-meshheading:10363689-Incidence,
pubmed-meshheading:10363689-Male,
pubmed-meshheading:10363689-Middle Aged,
pubmed-meshheading:10363689-Muromonab-CD3,
pubmed-meshheading:10363689-Retrospective Studies,
pubmed-meshheading:10363689-Severity of Illness Index,
pubmed-meshheading:10363689-Tacrolimus,
pubmed-meshheading:10363689-Treatment Outcome
|
pubmed:year |
1999
|
pubmed:articleTitle |
Efficacy of tacrolimus in the treatment of refractory rejection in heart and lung transplant recipients.
|
pubmed:affiliation |
Division of Cardiothoracic Surgery, University of Wisconsin School of Medicine, Madison, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|